Instrument Inactif

Communiqués Maxygen, Inc.

Actions

US5777761074

Cours en clôture Nasdaq Autres places de cotation
- ^USD	-

Communiqués

Débloquez toutes les actualités : Soyez le premier informé et réagissez avant les marchés !

Inscription 100% Gratuite

Maxygen, Inc. : Maxygen Announces Filing of Certificate of Dissolution; Delisting From NASDAQ	29/08/13	BU
Maxygen, Inc. : Maxygen Announces Approval of Dissolution by Shareholders	13/08/13	BU
Maxygen, Inc. : June 3, 2013	08/08/13	PU
Maxygen, Inc. : Maxygen Reports Second Quarter 2013 Financial Results	07/08/13	BU
Maxygen, Inc. : Maxygen Reports First Quarter 2013 Financial Results	03/06/13	PU
Maxygen, Inc. : Maxygen Announces Board Decision to Dissolve the Company	03/06/13	BU
Maxygen, Inc. : Maxygen Reports First Quarter 2013 Financial Results	03/05/13	BU
Maxygen, Inc. : Maxygen Reports Fourth Quarter and Year End 2012 Financial Results	12/03/13	BU
Maxygen, Inc. : Maxygen Announces Tax Treatment of 2012 Cash Distribution	29/01/13	BU
Maxygen, Inc. : Maxygen Announces Third Quarter 2012 Financial Results	06/11/12	BU
Maxygen, Inc. : Maxygen Announces Second Quarter 2012 Financial Results and Business Update	07/08/12	BU
Maxygen, Inc. : Maxygen to Receive $30 Million Payment from Bayer	14/05/12	BU
Maxygen, Inc. : Maxygen Reports First Quarter 2012 Financial Results	07/05/12	BU
Maxygen, Inc. : Maxygen Reports Fourth Quarter and Year End 2011 Financial Results	08/03/12	BU
Maxygen, Inc. : Maxygen Reports Fourth Quarter and Year End 2011 Financial Results	08/03/12	PU
Maxygen, Inc. : Maxygen Announces $10 Million Stock Repurchase Program	10/01/12	BU
Maxygen, Inc. : Maxygen Announces BARDA Decision Not To Award Contract for Development of MAXY-G34 for Acute Radiation Syndrome	09/11/11	BU
Maxygen, Inc. : Maxygen Reports Third Quarter 2011 Financial Results	07/11/11	BU
Maxygen, Inc. : Maxygen Announces Final Rejection of All Claims of Amgen ‘804 Patent in Inter Partes Reexamination Proceeding	10/10/11	PU
Maxygen, Inc. : Maxygen Announces Final Rejection of All Claims of Amgen '804 Patent in Inter Partes Reexamination Proceeding	10/10/11	BU

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Communiqués Maxygen, Inc.

Actions

US5777761074

Communiqués

Filtres